| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.743 | 6.779 | 3.897 | 4.206 | 3.275 | 2.905 | 3.099 | 3.108 | 8.082 | 3.304 |
| Total Income - EUR | 9.743 | 6.779 | 4.125 | 4.206 | 3.275 | 2.909 | 3.210 | 4.875 | 8.083 | 3.308 |
| Total Expenses - EUR | 14.220 | 12.884 | 8.552 | 4.008 | 2.925 | 1.788 | 1.507 | 11.284 | 1.593 | 4.700 |
| Gross Profit/Loss - EUR | -4.478 | -6.105 | -4.427 | 199 | 351 | 1.121 | 1.703 | -6.409 | 6.490 | -1.392 |
| Net Profit/Loss - EUR | -4.770 | -6.308 | -4.937 | 72 | 252 | 1.038 | 1.607 | -6.555 | 5.452 | -1.478 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Microbe Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.303 | 4.109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 739 |
| Current Assets | 4.818 | 2.860 | 4.008 | 3.555 | 6.603 | 9.065 | 9.994 | 4.808 | 11.410 | 7.258 |
| Inventories | 1.839 | 0 | 320 | 115 | 337 | 331 | 323 | 324 | 323 | 0 |
| Receivables | 2.508 | 2.520 | 2.673 | 2.458 | 2.438 | 2.775 | 3.618 | 376 | 374 | 62 |
| Cash | 471 | 340 | 1.015 | 981 | 3.827 | 5.959 | 6.052 | 4.108 | 10.712 | 7.196 |
| Shareholders Funds | -10.118 | -16.323 | -21.329 | -22.479 | -21.791 | -20.341 | -18.283 | -24.895 | -19.367 | -20.737 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23.239 | 23.293 | 25.337 | 26.034 | 28.394 | 29.405 | 28.276 | 29.703 | 30.794 | 28.785 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Microbe Srl